SCHEMBL3417552

SCHEMBL3417552

CC(=O)OC[C@H]1O[C@@H](n2cc(/C=C/Br)c(N)nc2=O)[C@H](OC(C)=O)[C@H]1Oc1ccccc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
PRKCA P17252 1/20 0.38
AKT1 P31749 1/20 0.38
PTK2 Q05397 1/20 0.38
TSHR P16473 1/20 0.37
PRKAB2 O43741 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PRKAG3 Q9UGI9 1/20 0.37
PRKAG2 Q9UGJ0 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
CA1 P00915 11/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2587230 0.89 ALDH1A1 (0.47) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL2587233 0.89 ALDH1A1 (0.47) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL3417558 0.88 ALDH1A1 (0.41) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL2583191 0.84 ALDH1A1 (0.41) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL2583188 0.84 ALDH1A1 (0.41) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL2581531 0.82 CA1 (0.42) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL2581530 0.82 CA1 (0.42) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL2585719 0.81 LMNA (0.50) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL2585720 0.81 LMNA (0.50) ALDH1A1LMNATP53MAPTTDP1
SCHEMBL2579634 0.79 LMNA (0.48) ALDH1A1LMNATP53MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411954-B1 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION PHARMASSET INC (US) 2010-12-15 EP disclosed